Vident Investment Advisory, LLC Atri Cure, Inc. Transaction History

Vident Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$27.62 - $35.58 $661,968 - $852,745	-23,967 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$19.65 - $30.28 $92,787 - $142,982	-4,722 Reduced 16.46%	23,967 $648,000
Q1 2018 May 14, 2018	BUY	$15.05 - $21.03 $17,533 - $24,499	1,165 Added 4.23%	28,689 $607,000
Q4 2017 Feb 15, 2018	BUY	$17.69 - $23.44 $486,899 - $645,162	27,524	27,524 $502,000

229

47.1M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.56B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.